| Stock: | In stock |
|---|---|
| Price: | On request |
Noncommunicable diseases (NCDs) – cardiovascular diseases, cancer, chronic respiratory diseases and diabetes – are the leading causes of death globally. According to WHO statistics, NCDs kill 41 million people annually, accounting for 71% of all deaths globally. Cardiovascular diseases account for the majority of NCD deaths, or 17.9 million people per year, followed by cancer (9.0 million), respiratory diseases (3.9 million) and diabetes (1.6 million).
Detection, screening and treatment of NCDs, as well as palliative care, are key components of the response to NCDs. Fortunately, biochemical testing plays a vital role in assessing the function of many organs and assessing disease progression. Accurate screening for early detection facilitates effective treatment.
POCT Prospectus
The global clinical chemistry market was valued at $8.4 billion in 2018. Overall, this
testing segment is growing at a modest 2% per year and will reach $9.1 billion by 2023 [1].
Currently, the total global dry chemical market is approximately $1.9 billion per year.
[1] The Worldwide Market for In Vitro Diagnostic Tests, 11th Edition
Chemcare Dry Chemistry Express Analyzer
|
|
|
|
Parameters for the biochemical cartridge
| Cat. № | Profiles | Test Name | Sample Type | Reaction Time (min.) | Sample Volume (µl.) | Measurement Range |
| W416 | Liver Function | ALT | Serum/Plasma | 2.5 | 20 | 5-800 U/L |
| W420 | AST | Serum | 2 | 20 | 10-800 U/L | |
| W414 | ALB | Serum | 1 | 7 | 10-60 g/L | |
| W412 | Kidney Function | UREA | Serum/Plasma | 2 | 7 | 2.5-40 mmol/L |
| W418 | CREA | Serum | 5 | 10 | 30-1000 μmol/L | |
| W413 | UA | Serum/Plasma | 2 | 7 | 120-1200 μmol/L | |
| W422 | Myocardial Enzyme | CK | Serum | 3 | 20 | 20-1600 U/L |
| W423 | CK-MB | Serum | 4 | 20 | 5-300 U/L | |
| W419 | LDH | Serum | 2 | 15 | 100-1800 U/L | |
| W426 | a-HBDH | Serum | 2 | 15 | 20-1000 U/L | |
| W411 | Emergency Treatment | a-AMY | Serum/Plasma | 2 | 7 | 20-1000 U/L |
| W424 | LPS | Serum | 3 | 10 | 5-300 U/L | |
| W417 | CHE | Serum | 2 | 10 | 200-12500 U/L | |
| W421 | ALC | Serum | 2 | 10 | 10.0-300.0 mg/dL | |
| W415 | Blood Routine Examination | HB | Whole Blood | 1 | 7 | 45-200 g/L |
| W425 | Blood Glucose | GLU | Serum | 2 | 7 | 1.00-25.00 mmol/L |